|
Difference in resistance rates between civil and prison patients |
|||||
| New cases |
Prison and civilian (N-948) |
Prison (N-184) |
Civil (N-764) |
OR (95%CI) |
RR (95%CI) |
|
|
|||||
| Inh* |
236 (24.9%) |
90 (48.9%) |
146 (19.1%) |
3.6 (2.5–5.1) |
2.6 (2.0–3.2) |
| Rif* |
192 (20.3%) |
71 (38.6%) |
121 (15.8%) |
3.0 (2.1–4.2) |
2.4 (1.9–3.1) |
| MDR TB* |
164 (17.3%) |
69 (37.5%) |
95 (12.4%) |
3.8 (2.6–5.5) |
3.0 (2.3–3.9) |
| S* |
215 (22.7%) |
91 (49.5%) |
124 (16.2%) |
4.5 (3.2–6.4) |
3.0 (2.5–3.8) |
| E* |
115 (12.1%) |
44 (23.9%) |
71 (9.3%) |
2.7 (1.8–4.2) |
2.6 (1.8–3.6) |
|
|
|||||
| Relapses |
Prison and civilian (N- 94) |
Prison (N-18) |
Civil (N-76) |
OR (95%CI) |
RR (95%CI) |
|
|
|||||
| Inh* |
38 (40.4%) |
16 (88.9%) |
22 (28.9%) |
16.4 (3.5–77.6) |
3.1 (2.1–4.5) |
| Rif* |
38 (40.4%) |
15 (83.3%) |
23 (30.3%) |
10.0 (2.5–36.5) |
2.8 (1.9–4.10 |
| MDR TB* |
32 (34.0%) |
15 (83.3%) |
17 (22.4%) |
14.7 (3.8–57.1) |
3.7 (2.3–5.9) |
| S* |
34 (36.2%) |
16 (88.9%) |
18 (23.7%) |
21.8 (4.5–104.3) |
3.8 (2.4–5.8) |
| E* |
23 (24.5%) |
12 (66.7%) |
11 (14.5%) |
10.2 (3.1–32.9) |
4.6 (2.4–8.7) |
|
*statistically significant at p < 0.05 | |||||
Balabanova et al. Respiratory Research 2006 7:44 doi:10.1186/1465-9921-7-44 |
|||||